Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to -$11.2 million.

  • Cellebrite DI's Change in Receivables rose 4923.8% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.2 million, marking a year-over-year increase of 5607.76%. This contributed to the annual value of $5.8 million for FY2024, which is 35667.11% up from last year.
  • Cellebrite DI's Change in Receivables amounted to -$11.2 million in Q3 2025, which was up 4923.8% from -$10.9 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Change in Receivables ranged from a high of $15.3 million in Q1 2024 and a low of -$24.4 million during Q3 2021
  • Its 5-year average for Change in Receivables is -$2.0 million, with a median of $1.7 million in 2025.
  • In the last 5 years, Cellebrite DI's Change in Receivables surged by 25526.17% in 2021 and then crashed by 20879.86% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Change in Receivables stood at $8.7 million in 2021, then grew by 29.37% to $11.2 million in 2022, then tumbled by 162.86% to -$7.1 million in 2023, then surged by 245.22% to $10.3 million in 2024, then plummeted by 209.37% to -$11.2 million in 2025.
  • Its last three reported values are -$11.2 million in Q3 2025, -$10.9 million for Q2 2025, and $1.7 million during Q1 2025.